Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Perfusion|April 16, 2024
Clinical outcomes in critically ill children on extracorporeal membrane oxygenation with severe thrombocytopeniaSonia Labarinas, Kalpana Norbisrath, Dana Johnson, et al.Atherosclerosis|December 12, 2018
The relationship between endothelial function and aortic valve calcification: Multi-Ethnic Study of AtherosclerosisMoshrik Abd Alamir, Michael Goyfman, Dana Johnson, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a 4-Azetidinyl-1-thiazoyl-cyclohexane CCR2 Antagonist as a Development CandidateXuqing Zhang, Cuifen Hou, Heather Hufnagel, et al.Journal of Clinical Apheresis|October 5, 2025
Plasma Exchange in the Setting of Immune-Mediated Multiple Organ Failure in the Cardiac ICU During ECMO: A Case SeriesSonia Labarinas, Kalpana Norbisrath, Ibeh Nnaemeka, et al.Pediatrics|September 4, 2007
Predictors of Mycobacterium tuberculosis infection in international adopteesAnna M Mandalakas, H Lester Kirchner, Sandra Iverson, et al.Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|April 22, 2026
Advancements in mapping, cardiac imaging, and ablation techniques for the management of ventricular tachycardiasAlejandro Sanchez-Nadales, Richard Amoateng, Aamir Husain Twing, et al.Bioorganic & Medicinal Chemistry Letters|November 28, 2012
Novel 2-aminooctahydrocyclopentalene-3a-carboxamides as potent CCR2 antagonistsChaozhong Cai, Fu-An Kang, Cuifen Hou, et al.Bioorganic & Medicinal Chemistry Letters|August 7, 2013
Discovery and SAR of 5-aminooctahydrocyclopentapyrrole-3a-carboxamides as potent CCR2 antagonistsChaozhong Cai, Dave F McComsey, Cuifen Hou, et al.Bioorganic & Medicinal Chemistry Letters|September 16, 2011
Design, synthesis and SAR of indazole and benzoisoxazole containing 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonistsXuqing Zhang, Heather Hufnagel, Cuifen Hou, et al.Bioorganic & Medicinal Chemistry Letters|January 9, 2013
A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonistsNalin L Subasinghe, James Lanter, Thomas Markotan, et al.Pageof 4